Stem Cells: Fundamentals and Types

Stem Cells: Fundamentals and Types

Introduction to Stem Cells

• Topic Overview:

  • This section covers the fundamental characteristics of stem cells, their types, and their contribution to tissue maintenance.

Definition of Stem Cells

• A stem cell is a unique type of cell characterized by:

  • Ability to Self-Renew: They can divide and produce identical stem cells.

  • Differentiation Potential: Can develop into various specialized cell types.

• Distinction from Terminally Differentiated Cells:

  • Terminally differentiated cells have reached their final state of maturity and function.

Key Characteristics of Stem Cells

• Not Terminally Differentiated:

  • Stem cells have not reached their final mature state.

• Unlimited Division:

  • Exhibit a form of cellular immortality by dividing without limit for the organism's lifetime.

• Self-Renewal:

  • Division results in two daughter cells: one maintains stem cell characteristics, and the other differentiates.

• Maintenance of Undifferentiated State:

  • They retain the ability to remain unspecialized until prompted to differentiate by signals.

Mechanism of Self-Renewal

• Ensures the maintenance of the stem cell pool.

• Only one daughter cell maintains stem characteristics to prevent depletion.

Adult Stem Cells

• Definition:

  • Adult organisms possess stem cells referred to as "adult stem cells" crucial for tissue repair.

• Presence and Abundance:

  • Found in many tissues, but exist in only small numbers (e.g., about 1 in 10,000 to 15,000 in bone marrow).

• Example of Adult Stem Cells:

  • Hematopoietic Stem Cells:

  • Responsible for generating all immune system cells and red blood cells.

Locations in the Body for Adult Stem Cells

• Bone Marrow

• Epithelium of the Skin: For skin cell replacement.

• Digestive System

• Blood Vessels

• Dental Pulp

• Brain: (especially in the cerebrum, responsible for learning and memory).

Division Rate and Control of Adult Stem Cells

• Rate:

  • Adult stem cells divide slowly and in a controlled manner in response to specific signals.

• **Purpose:

  • Replacement of differentiated cells that have reached maturity to dilute mutations.**

Potency: Embryonic vs. Adult Stem Cells

• Potency Definition:

  • Refers to a stem cell's ability to differentiate into different cell types.

Embryonic Stem Cells (ESCs)

• Pluripotent:

  • They can become any tissue type in the body.

Adult Stem Cells

• Multipotent:

  • They are generally limited in capacity compared to ESCs due to prior differentiation.

  • Example: A hematopoietic stem cell can produce blood cells but not stomach cells.

  • In Vitro vs. In Vivo: Adult stem cells show more plasticity in laboratory settings than in living systems.

Mechanisms of Cell Fate Determination

• How a single stem cell differentiates into daughter cells with varied fates:

  1. Divisional Asymmetry:

  • Unequal distribution of cytoplasmic contents results in different cell fates:

    • Identical genome but different cytoplasmic factors lead to different gene regulation.

  1. Environmental Asymmetry:

  • Differentiation influenced by microenvironments and signaling:

    • One daughter cell linked to its microenvironment maintains stem identity, while the other may differentiate after detachment.

Generating Large Numbers of Differentiated Cells

• Process:

  • The stem cell divides slowly, and the differentiating daughter cell (transit amplifying cell) undergoes rapid divisions (approximately 30) to produce large numbers of terminally differentiated cells.

Example: Hematopoietic Stem Cells (HSCs)

• HSCs: Multipotent adult stem cells in bone marrow, giving rise to all blood types.

• HSCs generate two main progenitor types:

  1. Common Lymphoid Progenitor (CLP):

  • Lymphatic cells (T cells, B cells, Dendritic cells, NK cells).

  1. Common Myeloid Progenitor (CMP):

  • Granulocytes and other myeloid cells (macrophages, red blood cells, platelets).

Developmental Biology Insights

• Most blood cells develop primarily in the bone marrow.

• Multipotency of HSCs:

  • Generates all blood types based on specific signals received.

• Committed Progenitor Cells:

  • HSCs give rise to progenitor cells for specific blood cell types, limiting potential.

Experimental Evidence: Mouse Studies

• Irradiation Experiment:

  • Mice were irradiated to kill blood cells, necessitating blood system reinstatement via:

  • Bone Marrow Transplantation:

    • Successful repopulation of the entire blood system using HSCs from donor mice.

  • Success illustrated by the feasibility of transplanting as few as five stem cells to restore blood function.

Clinical Applications: Human Stem Cell Transplantation

• Allogeneic Stem Cell Transplantation:

  • Pioneered by Dr. Donnall Thomas (Nobel Prize).

  • 1977 Study:

  • Involved 100 patients with blood cancers using HLA-matched donors.

  • Preparation: Total body radiation and chemotherapy to eliminate existing blood system before transplantation.

  • Outcome of the study showed 13 survivors out of 100, marking a significant advancement.

Modern Practices and Techniques

• Improved procedures and less toxic ablation techniques.

Autologous Stem Cell Transplantation

• Procedure involves:

  • Collection and freezing of patient's own stem cells.

  • Radiation and chemotherapy followed by re-infusion of patient's cells.

• Advantages:

  • No rejection issues due to genetic identity of stem cells.

Considerations for Transplant Type

• Congenital Mutations:

  • Autologous transplant ineffective if mutation present in all cells.

• Acquired Mutations:

  • Viable if cancer mutation isn't in the patient's stem cells, allowing healthy cells to be used.

Applications of Stem Cells: The "Skin Gun" for Burn Victims

• Severe Burns Issue:

  • Skin needs rapid replacement to prevent infection.

• Dr. George Garlock - Skin Cell Gun:

  • A device for rapidly depositing skin cells onto wounds.

• Process:

  1. Isolate healthy skin cells from patient's skin.

  2. Suspend cells in water and spray onto burned area.

• Advantages:

  • Speed: Entire process takes about 1.5 hours.

  • Rapid Healing: Notable cases show healing within days.

Cloning: Reprogramming Differentiated Cells

• Project Overview:

  • Aimed to explore reprogramming of differentiated cells to create new organisms.

• The Dolly the Sheep Experiment (1996):

  • Proved that differentiated cells could direct organism development.

Process of Somatic Cell Nuclear Transfer (SCNT) for Dolly

1. Donor Cell:

   • Adult cell from a white-faced ewe, semi-starved for remodeling.

2. Enucleated Egg Cell:

   • From another ewe, nucleus removed to form an enucleated egg.

3. Cell Fusion:

   • Combine enucleated egg with the donor nucleus.

4. Embryo Development/Insemination:

   • Cultured and implanted in surrogate mothers.

5. Outcome:

   • Dolly, genetically identical to the donor.

Significance and Controversies of Dolly

• Nuclear Totipotency:

  • Demonstrated that a differentiated cell's nucleus holds all necessary information for a complete organism.

• Reversibility of Differentiation:

  • Indicated that changes during differentiation are not permanent.

• Controversy:

  • Ethical debates heightened regarding cloning technology and Dolly's health issues.

Embryonic Stem Cells (ESCs)

• Introduction:

  • ESCs are pluripotent and can differentiate into all three germ layers (ectoderm, mesoderm, endoderm).

• Culturing Milestones:

  • Mouse ESC culture in 1981; human ESC in 1998.

• Directed ESC Differentiation Examples:

  • Specific signaling molecules applied to steer differentiation into target cell types.

Ethical Considerations in ESC Research

• Embryo Destruction Issues:

  • Obtaining ESCs necessitates the destruction of a blastocyst, a politically charged topic.

• NIH Guidelines:

  • Restrictions on funding for research using human ESCs; only approved lines may be used.

Induced Pluripotent Stem Cells (iPSCs)

Introduction to iPSCs

• Development by Dr. Shinya Yamanaka:

  • Aim to create pluripotent cells without embryo destruction by reprogramming differentiated cells.

• Characteristics:

  • Self-renewing and can differentiate into multiple cell types.

Mechanism of iPSC Reprogramming

1. Yamanaka Factors:

   • Four transcription factors identified (Oct4, Sox2, c-Myc, KLF4).

2. Reprogramming Process:

   • Reintroducing these factors into differentiated cells remodels chromatin and activates embryonic stem cell characteristics.

3. Delivery Systems:

   • Initially, a retrovirus was used; concerns over oncogenic potential arose.

Challenges of iPSCs

• Oncogenic Potential:

  • Retroviral integration raises cancer risk.

• Tumor Development:

  • Issues of teratoma formation from immature cells post-transplantation.

Advancements in iPSC Delivery Methods

• Non-Integrating Viral Vectors:

  • Avoid genomic changes while delivering reprogramming factors.

• RNA and Episomal Vectors:

  • Deliver reprogramming genes without altering the host genome.

Clinical Potential and Applications of iPSCs

1. Patient-Specific Disease Models:

   • Testing responses to drugs using patient's cells boosts personalized medicine.

2. Avoiding Immune Rejection:

   • Autologous iPSCs make transplants safer.

3. Research Directions:

   • Studying direct reprogramming methods for efficient therapy applications.

Conclusion

• Ongoing Trials:

  • Continued clinical trials on iPSCs hold promise for future therapies despite existing challenges.